Flu season ends with a whisper, not a bang.

Published Date: 14 Mar 2023

The 2022-2023 flu season is on the edge of life which has been predicted for half of January and most of February.

Read Full News

Latest News

Bioterrorism and Disaster Medicine

This collection of news, notices, articles, and related links provide healthcare professionals with the latest information and resources related to caring for those affected by volatile world events such as terrorist attacks, war, and natural disasters.

Certain Eye Conditions Linked to Higher Odds of Loneliness

Nonproliferative diabetic retinopathy and blindness are associated with increased odds of loneliness, a study finds.

Next Gen DSM Gets a New Name — and a New Vision

The next diagnostic manual is expected to place greater emphasis on evidence-based science, biomarkers, and AI, with the goal of becoming a continuously updated ‘living’ document.

EMA Backs Broader Pediatric Use of Poxvirus Vaccine

EMA’s positive opinion would lower the approved age for Imvanex from 12 years to 2 years for smallpox, mpox, and vaccinia virus disease.

Mezigdomide Triplet Improves PFS in R/R Multiple Myeloma

A phase 3 trial evaluates the efficacy of mezigdomide plus carfilzomib and dexamethasone vs carfilzomib and dexamethasone in patients with relapsed or refractory multiple myeloma.

Frailty in RA Is Linked to Disease Consequences, Not Age

Teaser: Frailty is more common in older adults with rheumatoid arthritis than in community peers and is associated with fatigue, comorbidities, and poorer physical function rather than age.

Todays Updates

Vistagen's Anxiety Disorder Drug Misses Main Goal in Late-stage Trial, Shares Plummet

Vistagen Therapeutics said on Tuesday its experimental anxiety disorder drug failed to meet the main goal of a late-stage ⁠trial testing its ability to reduce symptoms in...

Combined Models With AI Improve Breast Cancer Prediction

Combining mammography AI, polygenic, and clinical risk models improves 10-year breast cancer risk prediction compared with any single model.

Todays Updates

Vistagen's Anxiety Disorder Drug Misses Main Goal in Late-stage Trial, Shares Plummet

Vistagen Therapeutics said on Tuesday its experimental anxiety disorder drug failed to meet the main goal of a late-stage ⁠trial testing its ability to reduce symptoms in...

Combined Models With AI Improve Breast Cancer Prediction

Combining mammography AI, polygenic, and clinical risk models improves 10-year breast cancer risk prediction compared with any single model.

Latest News

This collection of news, notices, articles, and related links provide healthcare professionals with the latest information and resources related to caring for those affected by volatile world events such as terrorist attacks, war, and natural disasters.

Nonproliferative diabetic retinopathy and blindness are associated with increased odds of loneliness, a study finds.

The next diagnostic manual is expected to place greater emphasis on evidence-based science, biomarkers, and AI, with the goal of becoming a continuously updated ‘living’ document.

EMA’s positive opinion would lower the approved age for Imvanex from 12 years to 2 years for smallpox, mpox, and vaccinia virus disease.

A phase 3 trial evaluates the efficacy of mezigdomide plus carfilzomib and dexamethasone vs carfilzomib and dexamethasone in patients with relapsed or refractory multiple myeloma.

Teaser: Frailty is more common in older adults with rheumatoid arthritis than in community peers and is associated with fatigue, comorbidities, and poorer physical function rather than age.

News All Time

The $5 Million Doctor

1 in 5 doctors say their family’s net worth has crossed $5 million.

Positive Topline Results for Novel LSD Formulation in MDD

A single dose of the LSD-based therapy DT120 produced rapid antidepressant effects that remained significant through 12 weeks in a pivotal phase 3 trial of major depressive disorder.

Pfizer Trial Backs Paxlovid Dose for High-Risk Children

A post-marketing trial finds the oral antiviral achieves effective blood concentrations in at-risk children aged 6 years or older with mild-to-moderate COVID.

Trofinetide Approved for Rett Syndrome After Reexamination

The EMA reverses its previous decision and grants marketing authorization to the world’s first drug specifically approved for treating the syndrome.

Carcinogen Concerns Trigger Review of Rifadin Syrup

Europe will be reviewing the tuberculosis medication following concerns raised by the Dutch medicines agency.

New Parkinson’s Drug Combines Immediate and Slow Release

The EMA approves a new formulation of a levodopa-carbidopa combination to treat moderate-to-severe motor fluctuations in patients with Parkinson’s disease.

Is Creatine for Brain Health Worth a Try?

Research on creatine supplementation has moved from the gym to the brain lab, leading neurologist Heidi Moawad to review the data on creatine’s potential for improving cognitive health.

S1 Episode 2: Is Alcohol the Missing Piece in Your MASLD Workup?

Patients with MASLD often underreport alcohol use and even modest intake can block improvement. Drs VanWagner and Ajmera share practical tools to quantify intake, spot MetALD, and counsel patients effectively.

CGRP May Lower Weather-Related Migraine Risk

Preventive treatment may blunt the impact of weather-related migraine triggers, in what investigators say is a first for migraine prevention.

Hyperbaric Oxygen Therapy Can Help in Refractory Colitis

Hyperbaric oxygen therapy is well tolerated in treatment-refractory ulcerative colitis and enhances clinical outcomes alongside improvement in bowel perfusion.

Ontario Docs to Screen Younger Patients for Colon Cancer

Ontario Health is poised to lower the colorectal cancer screening age to 45 years on July 1.

Primary Care Meets Artificial Intelligence

As AI continues to evolve, its integration into primary care is revolutionizing patient diagnosis, treatment, and management.

Canada Introduces Safe Social Media Act to Protect Children

Canada wants to make social media safer for children, but experts say key questions about how the law will actually work remain unanswered.

Heartburn Meds in Pregnancy Not Linked to Child GI Risk

Gastrointestinal reflux is common during pregnancy.

Do Involuntary Admissions Affect Clinicians’ Mental Health?

Researchers are examining how involuntary psychiatric admissions affect emergency clinicians, with findings expected to inform future support and training programs.

HSSIB Warns on Safety Gaps in Online Prescribing

NHS systems have failed to keep pace with the rapid growth of independent online prescribing, leaving clinicians without the information they need to prescribe safely, HSSIB warns.

Recommended News For You

Lung Cancer Screening Rates in Eligible Adults Remain Low, Uneven

La FDA ha approvato Talzenna per trattare il cancro alla prostata metastatico che non è resistente alla castrazione.

Fitness levels for the heart and lungs are linked to a lower mortality from cancer in men.

examining differences in the rates of breast reconstruction following mastectomies.

Promising Results With Epcoritamab Monotherapy in Relapsed/Refractory CLL

Expert Q&A: A Drug Holiday for Metastatic Prostate Cancer?

Breast cancer prevention: How nurse practitioners and physician assistants can help

Recommended Articles For You

Impact of Hormone Therapy Cessation on Tumor Growth: Case Study of Ki-67 Reduction 

All You Need To Know About Cancer Antigen 27-29: Causes, Symptoms & Treatment 

Adjuvant Atezolizumab in TNBC: What Recent Trials Reveal About Its Role 

The New Era of Oncology: Key Updates and Clinical Insights 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Recent research suggests that vitamin supplements may increase the risk of developing cancer.

2.

An FDA panel supports the use of CAR T-cell therapy earlier in the treatment of multiple myeloma.

3.

In-person and Virtual Palliative Care Are Both Beneficial for Advanced Lung Cancer Patients.

4.

How cancer misinformation exploits the way we think

5.

Making informed decisions and managing regret after prostate cancer treatment

1.

A Closer Look at White Blood Cells in Urine: Uncovering the Causes and Treatments

2.

The New Frontier of Cancer Survivorship: Navigating the Long-Term Effects of Immunotherapy and Targeted Therapies

3.

The Future of Hematology: Innovations Every Doctor Should Know

4.

Know About Lymphangioma: Symptoms, Causes, and Treatments

5.

Omitting Axillary Dissection in Node-Positive Breast Cancer: Insights from the SENOMAC Trial

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part IV

2.

Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective

3.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

4.

A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma

5.

Efficient Management of First line ALK-rearranged NSCLC - Part IV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot